ruboxistaurin has been researched along with glucagon-like peptide 1 in 1 studies
| Studies (ruboxistaurin) | Trials (ruboxistaurin) | Recent Studies (post-2010) (ruboxistaurin) | Studies (glucagon-like peptide 1) | Trials (glucagon-like peptide 1) | Recent Studies (post-2010) (glucagon-like peptide 1) |
|---|---|---|---|---|---|
| 203 | 29 | 56 | 9,484 | 1,208 | 6,374 |
| Protein | Taxonomy | ruboxistaurin (IC50) | glucagon-like peptide 1 (IC50) |
|---|---|---|---|
| Glucagon-like peptide 1 receptor | Homo sapiens (human) | 0.0051 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ceriello, A; De Nigris, V; Genovese, S; La Sala, L; Pujadas, G; Testa, R | 1 |
1 other study(ies) available for ruboxistaurin and glucagon-like peptide 1
| Article | Year |
|---|---|
The pivotal role of high glucose-induced overexpression of PKCĪ² in the appearance of glucagon-like peptide-1 resistance in endothelial cells.
Topics: Cell Proliferation; Cell Survival; Cells, Cultured; Endoplasmic Reticulum Stress; Enzyme Inhibitors; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glucose; Human Umbilical Vein Endothelial Cells; Humans; Indoles; Maleimides; Protein Kinase C beta; Reactive Oxygen Species | 2016 |